Edward T. Maggio 16870 W. Bernardo Drive Suite 390 San Diego, CA 92127 (hereinafter “Inventor(s)),” have invented certain new and useful improvements in Multimodal Particulate Formulations X for which Application No. 12/1 16 842 was filed on May 7, 2008 in the United States Patent Office; WHEREAS, Aegis Therapeutics, LLC, a limited liability company of the State of California, having a place of business at 16870 W. Bernardo Drive Suite 390, San Diego, CA 92127, (hereinafter “Assignee”), is desirous of acquiring the entire right, title and interest in and to said Application(s) and the inventions disclosed therein, and in and to all embodiments of the inventions, heretofore conceived, made or discovered, whether jointly or severally, by said lnventor(s) (hereinafter collectively referred to as “Inventions”), and in and to any and all patents, inventor's certificates and other forms of protection (hereinafter “Patent(s)”) thereon granted in the United States, foreign countries, or under any international convention, agreement, protocol, or treaty.
NOW, THEREFORE, in consideration of good and valuable consideration acknowledged by said lnventor(s) to have been received in full from said Assignee: Said lnventor(s) do hereby sell, assign, transfer and convey unto said Assignee the entire right, title and interest (a) in
fullest extent the right, title and interest herein conveyed in the United States, foreign countries, or under any international convention, agreement, protocol, or treaty.
Such cooperation by said lnventor(s) shall include prompt production of pertinent facts and documents, giving of testimony, execution of petitions, oaths, specifications, declarations or other papers, and other assistance all to the extent deemed necessary or desirable by said Assignee (a) for perfecting in said Assignee the right, title and interest herein conveyed; (b) for prosecuting any applications covering said Inventions; (c) for filing and prosecuting substitute, divisional, continuing or additional applications covering said Inventions; (d) for filing and prosecuting applications for reissuance of any said Patent(s); (e) for interference or other priority proceedings involving said Inventions; and (f) for legal proceedings involving said Inventions and any applications therefor and any Patent(s) granted thereon, including without limitation reissues and reexaminations, opposition proceedings, cancellation proceedings, priority contests, public use proceedings, infringement actions and court actions; provided, however, that the expense incurred by said lnventor(s) in providing such cooperation shall be paid for by said Assignee.
‘ Docket Number 35401-714201 IN WITNESS WHEREOF said Inventor(s) have executed and delivered this instrument to said Assignee as of the dates written Bygflb'; (fir; _'